Please login to the form below

Not currently logged in
Email:
Password:

neurodegeneration

This page shows the latest neurodegeneration news and features for those working in and with pharma, biotech and healthcare.

Axovant joins ever-growing Alzheimer’s failure club

Axovant joins ever-growing Alzheimer’s failure club

have no effect on the underlying neurodegeneration in the disease.

Latest news

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    abnormalities including seizures, neurodegeneration, cognitive deficits and hypomyelination… it is completely unclear whether BACE could be targeted in a manner to affect amyloid processing in a therapeutic manner, without serious

  • Pharma deals in September 2015 Pharma deals in September 2015

    Gencia is also at the discovery phase in mitochondrial therapies in neurodegeneration, cardiovascular disease and other areas.

  • Pharma deals during February 2014 Pharma deals during February 2014

    adolescence, and ultimately neurodegeneration due to the formation of fatty yellow nodules (xanthomas) in the brain.

  • Interview: Mike Hutton, Lilly Interview: Mike Hutton, Lilly

    influence driving the neurodegeneration seen in the disease. ... of molecules throughout the cell – leading to neurodegeneration. “

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics